CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: sulfadiazine
Accession: CHEBI:9328
browse the term
Definition: A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
Synonyms: exact_synonym: 4-amino-N-(pyrimidin-2-yl)benzenesulfonamide
related_synonym: 2-sulfanilamidopyrimidine; 2-sulfanilylaminopyrimidine; 4-amino-N-2-pyrimidinylbenzenesulfonamide; Formula=C10H10N4O2S; InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14); InChIKey=SEEPANYCNGTZFQ-UHFFFAOYSA-N; N(1)-2-pyrimidinylsulfanilamide; N(1)-2-pyrimidylsulfanilamide; SMILES=Nc1ccc(cc1)S(=O)(=O)Nc1ncccn1; sulfadiazin; sulfadiazina; sulfadiazinum; sulfapyrimidine; sulphadiazine
xref: Beilstein:235192; CAS:68-35-9; DrugBank:DB00359; Drug_Central:2500; Gmelin:219136; HMDB:HMDB0014503; KEGG:C07658; KEGG:D00587; LINCS:LSM-5457
xref_mesh: MESH:D013411
xref: PMID:11431418; PMID:12811231; PMID:13037579; PMID:15907564; PMID:18706672; PMID:20244050; PMID:23206954; PMID:23245764; PMID:23270807; PMID:23322489; PMID:23396336; PMID:23411088; PMID:23411170; PMID:23704574; PMID:23707894; PMID:7378112; PMID:8429812; Patent:GB557055; Patent:US2407966; Patent:US2410793; Reaxys:235192; VSDB:1740; Wikipedia:Sulfadiazine
cyclic_relationship: is_conjugate_acid_of CHEBI:33127
Please select species to view GViewer data.
G
M
Cyp2c29
cytochrome P450, family 2, subfamily c, polypeptide 29
increases hydroxylation
ISO
CYP2C8 protein results in increased hydroxylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr19:39,275,488...39,319,157
Ensembl chr19:39,257,849...39,319,157
G
M
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
increases hydroxylation
ISO
CYP2C9 protein results in increased hydroxylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
M
Cyp2c66
cytochrome P450, family 2, subfamily c, polypeptide 66
increases hydroxylation
ISO
CYP2C9 protein results in increased hydroxylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr19:39,102,342...39,175,200
Ensembl chr19:39,102,342...39,175,516
G
R
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
increases hydroxylation
ISO
CYP2C8 protein results in increased hydroxylation of Sulfadiazine
CTD
PMID:15843491
G
H
CYP2C8
cytochrome P450 family 2 subfamily C member 8
increases hydroxylation
EXP
CYP2C8 protein results in increased hydroxylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
G
H
CYP2C9
cytochrome P450 family 2 subfamily C member 9
increases hydroxylation
EXP
CYP2C9 protein results in increased hydroxylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
G
R
Grin1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression
ISO
Sulfadiazine results in decreased expression of GRIN1 mRNA
CTD
PMID:34748853
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
M
Grin1
glutamate receptor, ionotropic, NMDA1 (zeta 1)
decreases expression
ISO
Sulfadiazine results in decreased expression of GRIN1 mRNA
CTD
PMID:34748853
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
G
H
GRIN1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression
EXP
Sulfadiazine results in decreased expression of GRIN1 mRNA
CTD
PMID:34748853
NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,139,154...137,168,756
G
R
Hmbs
hydroxymethylbilane synthase
decreases activity
EXP
Sulfadiazine decreases activity of purified Hmbs protein
RGD
PMID:6893114
RGD:26923963
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
G
M
Hmbs
hydroxymethylbilane synthase
decreases activity
ISO
Sulfadiazine decreases activity of purified Hmbs protein
RGD
PMID:6893114
RGD:26923963
NCBI chr 9:44,247,645...44,255,525
Ensembl chr 9:44,247,636...44,255,525
G
H
HMBS
hydroxymethylbilane synthase
decreases activity
ISO
Sulfadiazine decreases activity of purified Hmbs protein
RGD
PMID:6893114
RGD:26923963
NCBI chr11:119,084,881...119,093,549
Ensembl chr11:119,084,866...119,093,834
G
R
Il6
interleukin 6
multiple interactions
ISO
[Trimethoprim co-treated with Sulfadiazine] results in increased expression of IL6 protein
CTD
PMID:10888991
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
M
Il6
interleukin 6
multiple interactions
ISO
[Trimethoprim co-treated with Sulfadiazine] results in increased expression of IL6 protein
CTD
PMID:10888991
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
H
IL6
interleukin 6
multiple interactions
EXP
[Trimethoprim co-treated with Sulfadiazine] results in increased expression of IL6 protein
CTD
PMID:10888991
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
R
Lpo
lactoperoxidase
decreases expression
ISO
Sulfadiazine results in decreased expression of LPO mRNA
CTD
PMID:34748853
NCBI chr10:72,606,944...72,626,535
Ensembl chr10:72,606,944...72,626,535
G
M
Lpo
lactoperoxidase
decreases expression
ISO
Sulfadiazine results in decreased expression of LPO mRNA
CTD
PMID:34748853
NCBI chr11:87,697,254...87,716,940
Ensembl chr11:87,697,254...87,719,115
G
H
LPO
lactoperoxidase
decreases expression
EXP
Sulfadiazine results in decreased expression of LPO mRNA
CTD
PMID:34748853
NCBI chr17:58,238,584...58,268,518
Ensembl chr17:58,218,548...58,268,518
G
R
Mtor
mechanistic target of rapamycin kinase
decreases expression
ISO
Sulfadiazine results in decreased expression of MTOR mRNA
CTD
PMID:34748853
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
M
Mtor
mechanistic target of rapamycin kinase
decreases expression
ISO
Sulfadiazine results in decreased expression of MTOR mRNA
CTD
PMID:34748853
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
H
MTOR
mechanistic target of rapamycin kinase
decreases expression
EXP
Sulfadiazine results in decreased expression of MTOR mRNA
CTD
PMID:34748853
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
R
Nat2
N-acetyltransferase 2
increases acetylation
ISO
NAT2 protein results in increased acetylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
M
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
increases acetylation
ISO
NAT2 protein results in increased acetylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
G
H
NAT2
N-acetyltransferase 2
increases acetylation
EXP
NAT2 protein results in increased acetylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
G
R
Olig2
oligodendrocyte transcription factor 2
decreases expression
ISO
Sulfadiazine results in decreased expression of OLIG2 mRNA
CTD
PMID:34748853
NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152
G
M
Olig2
oligodendrocyte transcription factor 2
decreases expression
ISO
Sulfadiazine results in decreased expression of OLIG2 mRNA
CTD
PMID:34748853
NCBI chr16:91,016,745...91,025,567
Ensembl chr16:91,022,345...91,025,565
G
H
OLIG2
oligodendrocyte transcription factor 2
decreases expression
EXP
Sulfadiazine results in decreased expression of OLIG2 mRNA
CTD
PMID:34748853
NCBI chr21:33,025,935...33,029,185
Ensembl chr21:33,025,935...33,029,196
G
R
Shank2
SH3 and multiple ankyrin repeat domains 2
decreases expression
ISO
Sulfadiazine results in decreased expression of SHANK2 mRNA
CTD
PMID:34748853
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
G
M
Shank2
SH3 and multiple ankyrin repeat domains 2
decreases expression
ISO
Sulfadiazine results in decreased expression of SHANK2 mRNA
CTD
PMID:34748853
NCBI chr 7:143,531,819...143,979,780
Ensembl chr 7:143,555,665...143,978,231
G
H
SHANK2
SH3 and multiple ankyrin repeat domains 2
decreases expression
EXP
Sulfadiazine results in decreased expression of SHANK2 mRNA
CTD
PMID:34748853
NCBI chr11:70,467,854...71,253,228
Ensembl chr11:70,467,854...71,252,577
G
R
Slc6a4
solute carrier family 6 member 4
decreases expression
ISO
Sulfadiazine results in decreased expression of SLC6A4 mRNA
CTD
PMID:34748853
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
M
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
decreases expression
ISO
Sulfadiazine results in decreased expression of SLC6A4 mRNA
CTD
PMID:34748853
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
H
SLC6A4
solute carrier family 6 member 4
decreases expression
EXP
Sulfadiazine results in decreased expression of SLC6A4 mRNA
CTD
PMID:34748853
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all